NIH-funded research NIH-funded research

Detecting Metachromatic Leukodystrophy in Newborns

Official title: NEWBORN SCREENING PILOT STUDY FOR METACHROMATIC LEUKODYSTROPHY (MLD)

Funded at Nysdoh/health Research, INC. · NIH-11199664 · Data updated 2026-11-12

This study is testing a new way to check newborns for Metachromatic Leukodystrophy (MLD) and similar conditions right after they are born, so that if they have it, they can get help early and have a better chance at a healthier life.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNysdoh/health Research, INC.
NIH-funded
Lab location1 site (Menands, United States)
Project startSeptember 26, 2024
Project endSeptember 25, 2026
Funding year2024
Award (this year)$1,033,058
NIH project number75N94021D00018-0-759402400001-1
Project IDNIH-11199664 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are newborns who are screened for metabolic and genetic disorders shortly after birth.

Less likely to help

Patients who are not newborns or those who do not have a family history of metabolic disorders may not benefit from this research.

What this research studies

This research aims to implement a newborn screening program to identify Metachromatic Leukodystrophy (MLD) and related conditions early in life. By screening newborns for specific genetic markers, the study seeks to provide timely interventions that can significantly improve health outcomes. The approach involves testing newborns shortly after birth, allowing for early diagnosis and potential treatment before symptoms develop. This proactive strategy is crucial as untreated MLD can lead to severe neurological damage and other disabilities.

Why it matters

Potential benefit: If successful, this research could lead to earlier diagnosis and treatment of Metachromatic Leukodystrophy, significantly improving the quality of life for affected infants.

How similar studies have gone: Previous research has shown success in early detection and treatment of similar metabolic disorders through newborn screening programs.

Where this research is happening

  • Nysdoh/health Research, INC.
    Menands, United States
    Active

Researchers

  • Principal investigator: Caggana, Michelle — Nysdoh/health Research, INC.
  • Study coordinator: Caggana, Michelle

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.